METHODS FOR CANCER IMMUNOTHERAPY, USING LYMPHODEPLETION REGIMENS AND CD19, CD20 OR BCMA ALLOGENEIC CAR T CELLS

摘要

The present invention encompasses methods of cancer immunotherapy, and particularly methods of allogeneic cellular immunotherapy, using particular lymphodepletion regimens in combination with particular populations of chimeric antigen receptor T cells expressing anti CD19 CAR PBCAR0191, anti CD20 CAR PBCAR20A or anti BCMA CAR PBCAR269A.